WO2017050980A1 - Lactobacillus rhamnosus et surnageants de celle-ci pour l'inhibition d'agents pathogènes - Google Patents

Lactobacillus rhamnosus et surnageants de celle-ci pour l'inhibition d'agents pathogènes Download PDF

Info

Publication number
WO2017050980A1
WO2017050980A1 PCT/EP2016/072715 EP2016072715W WO2017050980A1 WO 2017050980 A1 WO2017050980 A1 WO 2017050980A1 EP 2016072715 W EP2016072715 W EP 2016072715W WO 2017050980 A1 WO2017050980 A1 WO 2017050980A1
Authority
WO
WIPO (PCT)
Prior art keywords
composition
pathogen
lactobacillus rhamnosus
milk
supernatants
Prior art date
Application number
PCT/EP2016/072715
Other languages
English (en)
Inventor
Corina Diana CEAPA
Jan Knol
Kees VAN LIMPT
Original Assignee
N.V. Nutricia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by N.V. Nutricia filed Critical N.V. Nutricia
Publication of WO2017050980A1 publication Critical patent/WO2017050980A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/175—Rhamnosus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Definitions

  • LMG Long Gracepsus .
  • LMG 18020 LMG 18025 or LMG 18030.
  • “Holding” is taken to mean a rapid thermization of the milk and makes it possible to destroy the vegetative microbial flora, including pathogenic forms. Its typical duration is from 4 to 10 minutes, in particular from 5 to 8 minutes, and in particular approximately 6 minutes.
  • homogenization is taken to mean the dispersion of the fatty substances in the milk-type substance into small fat globules.
  • the homogenization is carried out for example at a pressure of 100 to 280 bars, in particular 100 to 250 bars, in particular 100 to 200 bars, in particular approximately 200 bars.
  • This homogenization stage is purely optional. It is in particular absent from the production process of products with 0% fatty substances.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • General Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Nutrition Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

La présente invention concerne, dans des modes de réalisation, l'utilisation de Lactobacillus rhamnosus et/ou de surnageants de celle-ci pour l'inhibition d'agents pathogènes. La présente invention concerne en outre, dans des modes de réalisation, l'utilisation de Lactobacillus rhamnosus et/ou de surnageants de celle-ci dans le traitement, la prévention ou l'amélioration d'une maladie causée par un agent pathogène ou de symptômes associés ainsi que des compositions comprenant Lactobacillus rhamnosus et/ou des surnageants de celle-ci pour une utilisation selon des modes de réalisation de la présente invention.
PCT/EP2016/072715 2015-09-25 2016-09-23 Lactobacillus rhamnosus et surnageants de celle-ci pour l'inhibition d'agents pathogènes WO2017050980A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562232594P 2015-09-25 2015-09-25
US62/232,594 2015-09-25

Publications (1)

Publication Number Publication Date
WO2017050980A1 true WO2017050980A1 (fr) 2017-03-30

Family

ID=56990446

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2016/072715 WO2017050980A1 (fr) 2015-09-25 2016-09-23 Lactobacillus rhamnosus et surnageants de celle-ci pour l'inhibition d'agents pathogènes

Country Status (1)

Country Link
WO (1) WO2017050980A1 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021114659A1 (fr) * 2019-12-12 2021-06-17 石家庄君乐宝乳业有限公司 Lactobacillus rhamnosus x253 bénéfique pour la santé buccale, son procédé de séparation et de purification, et son utilisation
WO2021209600A1 (fr) 2020-04-16 2021-10-21 Chr. Hansen A/S Procédé de réduction de la croissance de la listeria dans des produits alimentaires

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009122042A2 (fr) * 2008-03-19 2009-10-08 Compagnie Gervais Danone Souche de lactobacillus rhamnosus

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009122042A2 (fr) * 2008-03-19 2009-10-08 Compagnie Gervais Danone Souche de lactobacillus rhamnosus

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
ENDO AKIHITO ET AL: "Evaluation of strain-specific primers for identification of Lactobacillus rhamnosus GG", FEMS MICROBIOLOGY LETTERS, vol. 337, no. 2, December 2012 (2012-12-01), pages 120 - 125, XP002763587 *
PETROVIC TANJA ET AL: "COMPARATIVE ANALYSIS OF THE POTENTIAL PROBIOTIC ABILITIES OF LACTOBACILLI OF HUMAN ORIGIN AND FROM FERMENTED VEGETABLES", ARCHIVES OF BIOLOGICAL SCIENCES, vol. 64, no. 4, 2012, pages 1473 - 1480, XP002763585 *
S PITHVA ET AL: "Antimicrobial Peptides of Probiotic Lactobacillus strains", 12 January 2012 (2012-01-12), pages 987 - 991, XP055314654, Retrieved from the Internet <URL:http://www.formatex.info/microbiology3/book/987-991.pdf> [retrieved on 20161027] *
TEJERO-SARINENA S ET AL: "In vitro evaluation of the antimicrobial activity of a range of probiotics against pathogens: Evidence for the effects of organic acids", ANAEROBE 2012 ACADEMIC PRESS GBR, vol. 18, no. 5, October 2012 (2012-10-01), pages 530 - 538, XP002763586, ISSN: 1075-9964 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021114659A1 (fr) * 2019-12-12 2021-06-17 石家庄君乐宝乳业有限公司 Lactobacillus rhamnosus x253 bénéfique pour la santé buccale, son procédé de séparation et de purification, et son utilisation
WO2021209600A1 (fr) 2020-04-16 2021-10-21 Chr. Hansen A/S Procédé de réduction de la croissance de la listeria dans des produits alimentaires

Similar Documents

Publication Publication Date Title
EP3554517B1 (fr) Composition probiotique comprenant des souches de lactobacillus rhamnosus et de lactobacillus paracasei
EP3845069B1 (fr) Streptococcus thermophilus négatif de saccharose pour une utilisation dans la préparation de produits fermentés
US20200323227A1 (en) Fermented dairy compositions and methods of preparing the same
KR101440490B1 (ko) 비피도박테리아의 성장 및 생존도를 개선하기 위한 아라비아 검의 용도
CA3043224C (fr) Streptococcus thermophilus a utiliser dans la preparation de produits fermentes
US11166473B2 (en) Lactobacillus rhamnosus for use in preparation of fermented products
EP3328208B1 (fr) Procédés de préparation de produits fermentés comprenant des bifidobactéries
WO2017050980A1 (fr) Lactobacillus rhamnosus et surnageants de celle-ci pour l&#39;inhibition d&#39;agents pathogènes
Vasiljevic et al. Cultured milk and yogurt
US10960033B2 (en) Compositions and methods for increasing or maintaining Faecalibacterium prausnitzii populations
CA3020355C (fr) Lactobacillus rhamnosus destine a etre utilise dans la preparation de produits fermentes
RU2774771C2 (ru) Ферментированные молочные композиции и способы их получения
WO2022118075A1 (fr) Acétobacter destiné à être utilisé dans la préparation de produits fermentés
CA3224311A1 (fr) Bifidobacteries pour utilisation dans la preparation de produits fermentes
Patel et al. I. SEMISOLID CULTURED DAIRY PRODUCTS
Hati Nutritional Benefits of Enriching Dairy Foods with Probiotics
Shah 22 Probiotics and fermented milks

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 16770502

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 16770502

Country of ref document: EP

Kind code of ref document: A1